Cargando…
Combination of cell transplantation and glial cell line-derived neurotrophic factor-secreting encapsulated cells in Parkinson's disease
A major limitation of cell transplantation for Parkinson's disease (PD) is the mediocre survival of the grafted cells. Facilitating graft survival may improve the functional outcomes of the transplanted cells. Here, we discuss our observations that combination of rat fetal ventral mesencephalic...
Autor principal: | Widmer, Hans R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187948/ https://www.ncbi.nlm.nih.gov/pubmed/30450417 http://dx.doi.org/10.4103/bc.bc_19_18 |
Ejemplares similares
-
Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson’s Disease
por: Whone, Alan L., et al.
Publicado: (2019) -
Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson’s disease
por: Whone, Alan, et al.
Publicado: (2019) -
The Effects of Progesterone on Glial Cell Line-derived Neurotrophic Factor Secretion from C6 Glioma Cells
por: Hassanzadeh, Parichehr, et al.
Publicado: (2012) -
The Non-Survival Effects of Glial Cell Line-Derived Neurotrophic Factor on Neural Cells
por: Cortés, Daniel, et al.
Publicado: (2017) -
S100B Protein, Brain-Derived Neurotrophic Factor, and Glial Cell Line-Derived Neurotrophic Factor in Human Milk
por: Li, Ruisong, et al.
Publicado: (2011)